National cross-sectional survey of health workers perceptions of COVID-19 vaccine effectiveness, acceptance, and drivers of vaccine decision-making

Executive Summary

Contract Number: CW2272645
POR Registration Number: 127-22 (HC POR 22-28)
Award Date: February 15, 2023
Delivery Date: November 24, 2023

Prepared for: Public Health Agency of Canada (PHAC)
Prepared by: Ipsos

Ce rapport est aussi disponible en français

For more information on this report, please contact the Public Health Agency of Canada (PHAC) at cpab_por-rop_dgcap@hc-sc.gc.ca

Executive summary

Background and objectives

Mass vaccination campaigns have significantly reduced the Coronavirus Disease 2019 (COVID-19) burden across the world. Although vaccines are considered the most effective tools for consistently preventing severe COVID-19 diseases, there are many barriers to vaccine uptake that threaten the health of Canadians and people across the world. Worldwide vaccine hesitancy (VH) has posed significant global concerns and become a widespread public health issue for successful immunization. VH and acceptance among the general population and health workers (HWs) play an important role in successfully controlling the COVID-19 pandemic.

Vaccinating HWs against COVID-19 has been a public health priority since rollout began in late 2020. Health care workers (HCWs) in contact with COVID-19 patients are at a higher risk of infection than the general population. Mitigating and reducing this risk is essential to protecting HWs' well-being and reducing the spread of COVID-19.

Limited information is available about SARS-CoV-2 infection rates, COVID-19 vaccines uptake, perceptions of COVID-19 vaccine effectiveness (VE), acceptance, and drivers of vaccine decision-making among different categories of HWs, such as health care professionals (HCPs), allied health workers (ALHWs) and auxiliary health workers (AUHWs) in Canada. Evaluating the real-world COVID-19 vaccine uptake and performance is critical for understanding the characteristics that influence these behavioural and attitudinal decisions among these different HW categories in Canada.

Overall objectives of the quantitative and the qualitative survey were to:

Methodology

To address the research objectives, a multi-mode research design was undertaken that included a quantitative and a qualitative component. Both components took place concurrently between May 8 and August 14, 2023, and were delivered in both official languages. Participants were HWs ≥18 years of age residing in Canada who were eligible for COVID-19 vaccination and exposed directly or indirectly to COVID-19 patients during our study period, from 2020 to 2023. This includes those who have stopped working for various reasons linked or not to public health measures related to mandatory vaccination in Canada.

The quantitative survey was disseminated using different approaches to reach the targeted HWs and collect the perspectives of as many HWs as possible: an open-link survey to HCPs', ALHWs', and AUHWs' organizations (regulatory bodies and professional associations); a unique link survey via panel sources (including general population panels and professions-based panels); and a snowballing method to share the survey with eligible peers and colleagues.

A total of 5,425 HWs (unweighted) participated in the quantitative online survey, of which respondents were excluded as they did not report their age or province of residence (n = 53). The remaining N= 5,372 eligible HWs (unweighted) were categorized into three main groups (unweighted): 2,278 HCPs; 2,278 ALHWs; and 807 AUHWs.

While this multi-frame approach reached a wide cross-section of the target population, the samples are based on self-selection and not a probability sample. The Standards for the Conduct of Government of Canada Public Opinion Research—Online Surveys state that results of non-probability online surveys should not be generalized to the overall target population. Therefore, the results cannot be extrapolated to the actual Canadian HWs' population, and no margin of sampling error can be calculated.

The qualitative research design was national in scope and delivered in both official languages. Additional effort was made to include equity-seeking groups. The qualitative findings are directional in nature and may not be extrapolated to a broader audience.A total of 33 HWs participated in the qualitative component conducted between May 2 and June 5, 2023, which consisted of eighteen (n = 18) in-depth interviews and four (n = 4) online focus groups with four to eight participants depending on the session.

Data were analyzed using a framework approach. Key behavioural determinants of COVID-19 vaccination decision-making were identified among the different categories of HWs by using the World Health Organization (WHO) Behavioural and Social Drivers of COVID-19 vaccination framework to inform the online quantitative and quantitative survey design and to frame the results.1, 2

Incentives

For the quantitative component, only respondents recruited through research panels (<15%) were incentivized to complete the survey.
For the qualitative component, Ipsos provided an honorarium to participants to attend in-depth interviews or focus groups to encourage full attendance and engagement.
Further details on incentives provided to quantitative and qualitative participants can be found in the Appendix.

Interpretation of report findings

For the purposes of analysis, the data for HCPs and ALHWs has been statistically weighted by profession/role and region to match proportions published by the Canadian Institute of Health Information (CIHI). The data for AUHWs has been weighted by region based on general population Census data. Unless otherwise stated, all data and proportions presented in this report are weighted data.

Contract value

The total contract value for the project was $295,579.75 including applicable taxes.

Key findings

The following section presents the main findings of the quantitative and qualitative research components. First, HWs' self-reported SARS-CoV-2 infection and vaccination history are described. This is followed by a discussion of their perceptions about the safety and effectiveness of COVID-19 vaccines, the factors that influenced their decisions about vaccination uptake, and lastly their attitudes toward COVID-19 vaccines and public health measures.

For the weighted results, a total of 5,372 respondents divided into three HWs categories was analyzed: n = 3,134 HCPs; n = 1,431 ALHWs; and n = 807 AUHWs. In each HW category, the majority of respondents were identified as female and approximately half of respondents were 40-59 years old. The proportion of HWs identified as Black, Indigenous, or other people of colour (BIPOC) were 34%, 32% and 43% respectively among HCPs, ALHWs and AUHWs. Most respondents reported residing in Ontario or Quebec, followed by Alberta and Northwest Territories, British Columbia, and Yukon. Fewer respondents reported residing in Atlantic provinces.

Self-reported SARS-CoV-2 infections and COVID-19 vaccination history

Perceptions of COVID-19 vaccine safety and effectiveness

COVID-19 vaccine decision-making

Degree of COVID-19 vaccine acceptance and hesitancy
Drivers of acceptance and hesitancy

There were several factors that influenced HWs' decisions to get vaccinated or not.

Attitudes toward COVID-19 vaccination

HWs were categorized into five distinct attitudinal groups based on key behavioural determinants and social factors in COVID-19 vaccination decision-making. Their COVID-19 vaccination status, degree of COVID-19 VH, and the role that vaccine mandates played in their decision to get COVID-19 vaccine were used to name and describe the following attitudinal groups as follows with their weighted proportions:

The qualitative analysis of the attitudinal groupings was further supported by the VH Matrix created by the Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organization (WHO).1 2 The Matrix groups determinants of VH are based on three spheres of influence: individual and group influences, contextual influences, and vaccine-specific influences.

Attitudes toward public health measures

Participants' attitudes toward public health measures, specifically mask mandates and other public measures taken during the pandemic (e.g., social distancing, quarantine protocols), tended to align with their levels of hesitation toward the COVID-19 vaccines. For example, Vaccine Confidents and Vaccine Supporters were more likely to be supportive of vaccine mandates than participants who were considered Mandate-Driven Vaccinees. In terms of other public health measures, there was slightly more variation in participants, with some contention around the pandemic lockdowns, and largely positive reactions toward other public health measures such as masking and social distancing.

Sources of COVID-19 related information

Participants got their information about COVID-19 vaccines from different sources, and the types of sources they consulted differed depending on their level of aversion or hesitancy toward the COVID-19 vaccines.

Conclusions

Throughout this research there were some common conclusions and implications that emerged, in both qualitative and quantitative components. The majority of HWs reported having received at least the COVID-19 primary series between 2020 and 2023. The most common reason for vaccination was to protect themselves, their families, or individuals living in their household from COVID-19. Vaccine mandates were another commonly reported reason for getting vaccinated, indicating that maintaining their job was one of the reasons they decided to get vaccinated, and 11% of HWs indicating it was the only reason.

The qualitative findings on drivers of VH aligned with the quantitative finding. HWs had strong support for vaccines in general. However, Vaccine Hesitants, Mandate-Driven Vaccinees and Unvaccinated respondents tended to mention concerns around the safety and effectiveness of COVID-19 vaccines, particularly among nurses and ALHWs. These may act as areas for further research or analysis, or simply considerations moving forward when looking at larger scale public health responses.

POLITICAL NEUTRALITY STATEMENT

I hereby certify, as a Representative of Ipsos, that the deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Government of Canada's Policy on Communications and Federal Identity and Directive on the Management of Communications. Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, party standings with the electorate, or ratings of the performance of a political party or its leaders.

Mike Colledge, President
Ipsos Public Affairs
Signed on 9.25.23